Adrenergic receptor signaling in adipocytes controls not only the hydrolysis of triglycerides as fuel for other organs but is also a driver of brown adipocyte thermogenesis and energy consumption. As the appearance of these mitochondria-rich, thermogenically active cells in 'white' adipocyte depots is correlated with resistance to overnutrition and glucose intolerance, the molecular basis of their genesis and metabolic activity needs to be understood. b-adrenergic receptors regulate the enzymatic machinery for lipolysis and fuel utilization. They also coordinately stimulate the transcription of genes that support the specific functions of white and brown adipocytes. They accomplish this through the activation of a network of signaling pathways that include cAMP-dependent protein kinase and members of the mitogen-activated protein kinase family. In brown adipocytes, these kinases control the transcription of nuclear factors such as peroxisome proliferator-activated receptor-g coactivator-1s, as well as other molecules discovered to respond to adrenergic signals, to increase mitochondrial biogenesis and uncoupling protein-1 (UCP1) expression. However, it is also important to understand the mechanisms that may actively repress these energy-wasting processes. Toward that end, we provide evidence for an important role for the nuclear receptor LXRa as a cAMP-and oxysterol-dependent transcriptional repressor of the Ucp1 gene. Adipocytes from LXRa-null mice have increased expression of most 'markers' of brown adipocytes, increased mitochondrial mass and uncoupled respiration. These studies reveal potential new targets and directions for controlling the relative levels of white versus brown adipocytes as a means of metabolic fuel utilization in the struggle against obesity and related metabolic diseases.
Introduction
The sympathetic nervous system (SNS) controls (i) mobilization of stored energy and (ii) adaptive thermogenesis in adipose tissue through the activation of b-adrenergic receptors (bARs). All three known bAR subtypes are expressed in adipocytes. It is well established that bARs are coupled to the heterotrimeric G-protein Gs and to adenylyl cyclase, resulting in elevated levels of intracellular cAMP and activation of cAMP-dependent protein kinase (PKA). PKA has been considered as the ultimate component responsible for activating lipolytic enzymes and for expression in brown adipocytes of the genes encoding uncoupling protein-1 (UCP1) and peroxisome proliferator-activated receptor-g coactivator-1a (PGC-1a). However, besides this classic pathway, additional signaling cascades emanate from bARs in adipocytes, including the ERK and p38 mitogen-activated protein (MAP) kinase pathways (Figure 1 ), which have roles in regulating fuel mobilization and thermogenesis. [1] [2] [3] The p38 MAP kinase pathway has been of particular interest to us as we unexpectedly observed that its activation in response to PKA regulated the expression of Ucp1 and Pgc1a genes in brown adipocytes ( Figure 2 ). This PKA-p38 pathway also exists in white adipocytes, including human adipocytes, and yet its function in this cell type is still unclear to us; however, new studies on a targeted deletion of p38a MAP kinase in adipose tissue are proving to be informative in defining its role. The essential role of SNS in the control of adipose tissue metabolism is further exemplified by mice deficient in the synthesis of noradrenaline or in the expression of bARs. In these mutants, there is an absence of brown adipose tissue (BAT) that is replaced by white adipose tissue (WAT).
A similar loss of functioning BAT is observed in animals that have been maintained at thermoneutrality. [6] [7] [8] Altogether, these results suggest that mechanisms exist whereby b-agonists have the potential to promote postnatal changes in the WAT/BAT ratio, which could possibly induce weight loss in humans as is observed in laboratory animals such as adult dogs and rhesus monkeys. 9-14 These latter two species are similar to humans in that, unlike rodents, they do not retain large discrete depots of BAT in adulthood, yet they can still exhibit mixed white and brown adipocyte populations.
Owing to this remarkable plasticity of adipose tissue, it has been largely assumed that white and brown adipocytes derive from a common progenitor cell during development. However, the most recent evidence to emerge is that precursor cells of brown adipocytes possess a gene expression/transcription factor profile more closely resembling skeletal muscle than white adipocytes. 15 Recent work has led to the discovery of molecules such as PGC-1 16 and prdm16, Figure 1 The three bARs in adipocytes all couple to heterotrimeric Gs to increase cyclic AMP (cAMP) production, but they are also able to activate other signaling pathways in adipocytes that affect metabolism. cAMP binds to the protein kinase A (PKA) regulatory subunit, which, in adipocytes, is usually the membraneassociated Type II kinase bound to an A-kinase anchoring protein (AKAP). The catalytic subunit (PKA-Cat) is released to phosphorylate its various targets, such as lipases and the lipid droplet protein perilipin, which is a very abundant and heavily phosphorylated target of PKA. Events downstream of PKA allow the bARs to activate the p38 MAP kinase as well. The adipocyte b 3 AR is also able to activate the ERK MAP kinase pathway by a novel process of direct binding of Src and related signaling molecules to conserved intracellular regions; one consequence of this ERK activation is lipolysis that is independent of that activated by PKA. Not shown for simplicity: the b 1 AR and b 2 AR can also be phosphorylated by PKA and G-protein-coupled receptor kinases. These phosphorylation events on b 1 AR and b 2 AR desensitize their ability to activate adenylyl cyclase, but on the other hand initiate binding of other proteins to activate the ERK MAP kinase pathway. Note that the b 3 AR does not seem to be phosphorylated. Figure 2 bAR activation of p38 MAP kinase in brown adipocytes activates the transcription of Ucp1 and Pgc-1a genes for adaptive thermogenesis, mitochondrial biogenesis and fatty acid oxidation. Direct targets of p38 MAP kinase include the PGC-1a coactivator and the transcription factor ATF-2. The biochemical steps (dashed arrow) between PKA and the p38 MAP kinase model are not yet defined, but current results indicate that the p38a isoform and MAP kinase kinase-3 (MKK3)) are required, together with a JIP scaffold. The identity of the remaining components is a work in progress.
bAR signaling networks of brown fat S Collins et al remains to be discovered. This view now seems to be shared by the other speakers at this meeting.
Our approach to this question has been to explore the signaling pathways that emanate from bARs in white and brown adipocytes in detail and examine how they activate the enzymatic machinery for lipolysis and fuel utilization, as well as coordinately stimulate transcription of the genes that support the specific functions of white and brown adipocytes. In the case of the brown adipocyte phenotype, those defining features are the control of UCP1 and mitochondrial biogenesis. From such efforts we uncovered the PKA-p38a MAP kinase pathway to control factors that bind to the important Ucp1 gene enhancer, and in addition also identified a role for the 'orphan nuclear receptor' NOR-1, a member of the NR4A family, as a factor that robustly increases in response to cAMP and augments the initial transcriptional activation of the Ucp1 gene at a more distal site. 20 However, in addition to our efforts to work out these 'activating' or 'stimulatory' mechanisms, it is equally important to identify and understand the factors that actively repress a given biological process. 26, 27 A question yet to be answered is what functions do these molecules share in common that, in their absence, lead to a significant shift in the expression of UCP1 and production of thermogenically active brown adipocytes within typical WAT depots? We chose to focus on the role of LXRFspecifically LXRaFin the regulation of Ucp1 gene transcription and brown adipocyte thermogenesis, because we had noticed a potential LXR binding site (direct repeat spaced by 4 (DR-4)) in an important 'enhancer' region of the Ucp1 gene (Figure 3) , and mice lacking LXRs 24 have a lean phenotype and dramatic increase in UCP1 expression in white fat. Together, this suggested to us that LXR might function as a direct repressor of Ucp1 gene transcription through this DR-4 binding site. Conceptually, this was an attractive hypothesis, as the role of LXRs to promote lipogenesis and energy storage is diametrically opposed to an energy-wasting process such as brown fat thermogenesis. As the phenotype of adipose tissues and isolated cells from the LXRaÀ/À mouse was essentially identical to that of the LXRaÀ/À:LXRbÀ/À 'double knockout' with regard to Ucp1 gene expression, 28 the evidence pointed to a specific role for LXRa in this process. Such a role for LXRa was revealed by the following studies. As we previously reported, using cultured brown adipocytes, we could show that under conditions that mimicked SNS activation, such as treatment with the bAR agonist isoprenaline (Iso) or the adenylyl cyclase activator forskolin (Fsk), the ability to increase Ucp1 gene transcription was significantly blunted in the presence of an LXR ligand. 28 At the same time, LXR ligands still stimulate the expression of known target genes such as sterol regulatory element-binding protein-1 (Srebp-1), and also have no effect on cAMPdependent Pgc1a gene expression. LXRa was found to bind to the Ucp1 DR-4 element in gel shift and chromatin bAR signaling networks of brown fat S Collins et al immunoprecipitation experiments, and mutations within the DR-4 eliminated both binding and the ability to function as a repressor. 28 An interesting facet of these studies was the observation that when mouse embryo fibroblasts from wildtype or LXRa-null mice were differentiated into adipocytes in culture, there was a remarkable acquisition of most features of a 'brown' adipocyte by LXRaÀ/À cells, as shown in Figure 4 . This included the expression levels of a battery of genes that are typically expressed in brown adipocytes (Figure 4a) , as well as a greater density of mitochondria and increased oxygen consumption; a significant fraction of which were uncoupled (Figure 4b ). The mechanism underlying this transcriptional repression is still not completely clear but seems to involve two important parameters: (i) the availability of an LXR ligand and (ii) the competition for occupancy of the closely spaced DR-4 and DR-1 elements of the Ucp1 enhancer, as illustrated in Figure 5 . From all available data, the repression of Ucp1 gene transcription that is activated by the PKA-p38 MAP kinase pathway requires an LXR ligand. We should recall that the levels of LXRa transcripts seem to be equally abundant in both white and brown adipocytes. Therefore, the synthesis and/or degradation of the ligand(s) must be a key factor in this regulation. Although the exact identification of the biologically active oxysterols that function as LXR ligands is still unclear, 29 the enzymes involved in their production 30 and elimination 31, 32 could have a key role. In light of this, it is interesting that the expression of cholesterol 25-hydroxylase, one of the enzymes of oxysterol synthesis, is approximately 30 times greater in white fat than in brown fat (see Supplementary data in Wang et al.
28
). Another clue to the molecular mechanism of how LXRa might repress Ucp1 gene transcription was gleaned from the phenotype of RIP140À/À mice, which exhibit a phenotype very similar to that of LXRaÀ/À, including reduced fat mass, increased Ucp1 gene expression in WAT and the ability of RIP140 to bind somewhere in the Ucp1 enhancer. 23 From this we postulated that, in the presence of an LXR ligand, LXRa might be the receptor to which RIP140 is recruited to facilitate transcriptional repression. As described in detail in our recent publication, 28 the repression of Ucp1 gene transcription by LXR agonists and the accompanying elimination of peroxisome proliferator-activated receptor-g binding required the presence of both RIP140 and LXRa. This naturally leads to the next question to be answered: how the binding of LXRa to the Ucp1 gene and the recruitment of RIP140 are controlled? Our new findings suggest that phosphorylation of LXRa is a necessary part of the mechanism. In cultured brown adipocytes, LXRa is phosphorylated in a PKA-dependent manner; however, PKA itself is not the kinase involved (H Wang et al., unpublished). Functionally, phosphorylation of LXRa does not seem to be required for binding to the DR-4 sequence, but for the ligand-dependent recruitment of RIP140 (H Wang et al., unpublished). By understanding the protein-protein interactions between LXRa and RIP140 that are mediated by this phosphorylation, it will be an important step in understanding this biology and to possibly being able to regulate it. The recent recognition of brown fat in adult humans, as discussed by Cannon and Nedergaard 33 , makes this notion plausible. Concerns have been raised that if such a 'treatment' option were developed for humans, a chronic increase in such oxidative metabolism will cause excess 'reactive oxygen species' and oxidative damage, thus promoting rather than protecting against insulin resistance and atherosclerosis and, in addition, generally accelerating the 'aging process'. However, respiration per se is not the culprit. Highly active and respiring brown fat, the mitochondrial respiration of which is significantly uncoupled, can maintain a relatively low mitochondrial membrane potential and is therefore not at risk for generating large quantities of reactive oxygen species. Thus, it would seem that as long as the mitochondrial membrane potential remains relatively bAR signaling networks of brown fat S Collins et al low, with sufficient levels of (i) oxygen for reduction to H 2 O, (ii) adenosine diphosphate for conversion to adenosine triphosphate and functioning transport processes within the mitochondria, and as long as molecules such as UCP2 are in sufficient supply, a high rate of respiration is not necessarily detrimental.
Summary
The crucial role of SNS to regulate adipocyte metabolism, expand the mass and thermogenic capacity of BAT and promote the 'appearance' of thermogenically competent brown adipocytes within WAT depots has been known for many years to be the provenance of bAR receptors and their second messenger, cAMP. The elements in the biochemical pathways that orchestrate these events have proven to be a more intricate web than previously thought, with elements still to be identified to complete the path. The search to identify molecules and pathways that increase brown adipocyte density and activity in mammals has been going on for decades. Uncovering those pathways that actively oppose or repress the expression of UCP, and possibly a broader program of transcription of genes involved in When an LXR ligand is present (yellow diamond in step 1), the nuclear corepressor RIP140 is recruited to the complex (step 2), and the critical regulator peroxisome proliferator-activated receptor (PPAR) is eliminated from its DR-1 binding site (step 3), the net result of which is repression of Ucp1 gene transcription.
bAR signaling networks of brown fat S Collins et al mitochondriogenesis, fat oxidation and uncoupling, has the potential to reveal molecular switches that may permit expansion of brown adipocytes to prevent or reverse obesity and metabolic disease by increasing energy expenditure and oxidative respiration. Exciting times are ahead for discoveries in these signaling and regulatory cascades.
